vTv Therapeutics Management
Management criteria checks 0/4
vTv Therapeutics' CEO is Paul Sekhri, appointed in Aug 2022, has a tenure of 1.58 years. total yearly compensation is $2.00M, comprised of 10% salary and 90% bonuses, including company stock and options. directly owns 0.71% of the company’s shares, worth $459.15K. The average tenure of the management team and the board of directors is 1.3 years and 1.6 years respectively.
Key information
Paul Sekhri
Chief executive officer
US$2.0m
Total compensation
CEO salary percentage | 10.0% |
CEO tenure | 1.6yrs |
CEO ownership | 0.7% |
Management average tenure | 1.3yrs |
Board average tenure | 1.6yrs |
Recent management updates
Recent updates
Will vTv Therapeutics (NASDAQ:VTVT) Spend Its Cash Wisely?
May 11vTv Therapeutics GAAP EPS of -$0.04
Aug 16vTv stock soars 18% on $10M equity investment by CinRx Pharma
Jul 25We Think vTv Therapeutics (NASDAQ:VTVT) Needs To Drive Business Growth Carefully
Aug 17The Director of vTv Therapeutics Inc. (NASDAQ:VTVT), Richard Nelson, Just Bought A Few More Shares
Mar 03vTv Therapeutics inks licensing deal for HPP971, shares up 11%
Dec 15MacAndrews & Forbes buys 625K shares of vTv Therapeutics
Dec 11vTv Therapeutics raises $47M via stock purchase agreement
Nov 24CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$20m |
Sep 30 2023 | n/a | n/a | -US$22m |
Jun 30 2023 | n/a | n/a | -US$19m |
Mar 31 2023 | n/a | n/a | -US$17m |
Dec 31 2022 | US$2m | US$200k | -US$19m |
Compensation vs Market: Paul's total compensation ($USD2.00M) is above average for companies of similar size in the US market ($USD661.05K).
Compensation vs Earnings: Insufficient data to compare Paul's compensation with company performance.
CEO
Paul Sekhri (65 yo)
1.6yrs
Tenure
US$2,001,433
Compensation
Mr. Paul J. Sekhri, M.Sc. is Director at AdhereTech Inc. since February 7, 2024. He serves as Chief Executive Officer, President & Director of vTv Therapeutics Inc. since august 01, 2022. He served as Inde...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 1.6yrs | US$2.00m | 0.71% $ 459.2k | |
Executive VP & CFO | 1.3yrs | US$800.05k | no data | |
Chief Accounting Officer | no data | US$434.75k | no data | |
Executive VP of Corporate Development & Director | 1.6yrs | US$547.40k | 0.062% $ 40.1k | |
Chief Scientific Officer & Executive VP | no data | no data | no data | |
Chief Administrative Officer | no data | no data | no data | |
Executive VP & General Counsel | 1.1yrs | no data | no data | |
Chief Medical Officer | less than a year | no data | no data |
1.3yrs
Average Tenure
57yo
Average Age
Experienced Management: VTVT's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 1.6yrs | US$2.00m | 0.71% $ 459.2k | |
Executive VP of Corporate Development & Director | 3.3yrs | US$547.40k | 0.062% $ 40.1k | |
Independent Director | 1.7yrs | US$41.00k | 0.026% $ 16.7k | |
Director | less than a year | no data | no data | |
Director | no data | no data | no data | |
Director | less than a year | no data | no data | |
Director | 1.7yrs | US$31.55k | 0.026% $ 16.7k |
1.6yrs
Average Tenure
55yo
Average Age
Experienced Board: VTVT's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.